Physician profile
Sina A Joorabchi
NPI 1225296924
$76,213.27
in general payments reported to CMS, 2019-2025
18 companies · $46K in 2025
The $46K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,597 · 2020: $1,418 · 2021: $3,120 · 2022: $3,082 · 2023: $6,606 · 2024: $13K · 2025: $46K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $55K · Travel and Lodging: $4,899 · Food and Beverage: $4,798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $55,300.00 |
| Travel and Lodging | $4,898.60 |
| Food and Beverage | $4,798.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $61,968.41 | 2021-2025 | Propel, Nuvent, Straightshot |
| Aerin Medical INC. | $4,220.94 | 2019-2025 | |
| Intersect Ent, INC. | $4,034.04 | 2019-2022 | |
| Smith+Nephew, INC. | $1,916.51 | 2019-2025 | Tula, Halo |
| Inspire Medical Systems, INC. | $768.60 | 2019-2024 | Inspire |
| Stryker Corporation | $680.28 | 2019-2021 | |
| Genzyme Corporation | $548.69 | 2020-2025 | |
| Optinose US, INC. | $517.60 | 2019-2025 | |
| Acclarent, INC | $447.28 | 2019-2022 | |
| Medtronic USA, INC. | $328.00 | 2019-2020 | |
| Alk-Abello, INC | $195.33 | 2020-2022 | |
| Glaxosmithkline, LLC. | $170.69 | 2023-2024 | Nucala |
| Regeneron Healthcare Solutions, INC. | $168.84 | 2022-2023 | Dupixent |
| Xoran Technologies LLC | $117.05 | 2021 | |
| Kaleo, INC. | $67.33 | 2019-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fisher & Paykel Healthcare INC | $24.21 | 2024 | Fisher & Paykel Healthcare |
| Mylan Pharmaceuticals INC. | $23.09 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sina Joorabchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.